Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Saffron As a Promising Therapy for Diabetes and Alzheimer's Disease: Mechanistic Insights Publisher Pubmed



Sanaie S1 ; Nikanfar S2 ; Kalekhane ZY3, 4 ; Azizizeinalhajlou A5, 6 ; Sadigheteghad S7 ; Arajkhodaei M1, 8 ; Ayati MH1, 9 ; Andalib S10
Authors

Source: Metabolic Brain Disease Published:2023


Abstract

The prevalence of both Alzheimer's disease (AD) and diabetes mellitus is increasing with the societies' aging and has become an essential social concern worldwide. Accumulation of amyloid plaques and neurofibrillary tangles (NFTs) of tau proteins in the brain are hallmarks of AD. Diabetes is an underlying risk factor for AD. Insulin resistance has been proposed to be involved in amyloid-beta (Aβ) aggregation in the brain. It seems that diabetic conditions can result in AD pathology by setting off a cascade of processes, including inflammation, mitochondrial dysfunction, and ROS and advanced glycation end products (AGEs) synthesis. Due to the several side effects of chemical drugs and their high cost, using herbal medicine has recently attracted attention for the treatment of diabetes and AD. Saffron and its active ingredients have been used for its anti-inflammatory, anti-oxidant, anti-diabetic, and anti-AD properties. Therefore, in the present review paper, we take account of the clinical, in vivo and in vitro evidence regarding the anti-diabetic and anti-AD effects of saffron and discuss the preventive or postponing properties of saffron or its components on AD development via its anti-diabetic effects. © 2022, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Other Related Docs
9. Amelioration of Stz-Induced Nephropathy in Diabetic Rats by Saffron Hydro Alcoholic Extract, Hormone Molecular Biology and Clinical Investigation (2021)